Lung cancer drug combo study halted early
NCT ID NCT06173505
First seen Apr 06, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested a new drug called vudalimab combined with chemotherapy for people with advanced non-small cell lung cancer. The goal was to find the right dose and see if it works better than the standard treatment. The study was stopped early, and only 28 people took part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NONSQUAMOUS NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhua Christian Hospital
Changhua, 500, Taiwan
-
Eastern Connecticut Hematology and Oncology Associates
Norwich, Connecticut, 06360, United States
-
Hematology Associates of Fredericksburg
Fredericksburg, Virginia, 22408, United States
-
Hospital Clinic i Provincial de Barcelona
Barcelona, 08036, Spain
-
Hospital Clínico San Carlos
Madrid, 28040, Spain
-
Hospital Sultan Ismail
Johor Bahru, 81100, Malaysia
-
Hospital Umum Sarawak
Kuching, 93586, Malaysia
-
Hospital Universitario La Paz
Madrid, 28046, Spain
-
Institut Català d'Oncolgia de Girona
Girona, 17007, Spain
-
Institut Kanser Negara
Putrajaya, 62250, Malaysia
-
Jessa Ziekenhuis - Campus Virga Jesse
Hasselt, 3500, Belgium
-
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 807, Taiwan
-
NEXT Oncology-Hospital Quirónsalud Barcelona
Barcelona, 08023, Spain
-
Palo Verde Cancer Specialists
Glendale, Arizona, 85304, United States
-
St. Lukes (Agios Loucas) Hospital
Thessaloniki, 552 36, Greece
-
The Netherlands Cancer Institute - Antoni van Leeuwenhoek
Amsterdam, North Holland, 1066 CX, Netherlands
-
ULS do Alto Ave, EPE - Hospital da Senhora da Oliveira Guimarães
Guimarães, 4835-044, Portugal
Conditions
Explore the condition pages connected to this study.